Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

AstraZeneca's top products based on revenue 2015-2018

Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)

by Matej Mikulic, last edited Aug 27, 2019
AstraZeneca's top products based on revenue 2015-2018 AstraZeneca is a global biopharmaceutical company with several leading pharmaceutical products. As of 2018, AstraZeneca’s top pharmaceutical product by revenue was Symbicort, an inhaler used in the treatment of asthma and COPD. During that year Symbicort generated about 2.6 billion U.S. dollars in revenue for the company. The second-highest revenue generator for AstraZeneca in the same year was Nexium, a drug used in the treatment of acid reflux disease. Nexium generated about 1.7 billion U.S. dollars in revenue during that year.
AstraZeneca company profile

AstraZeneca is a global pharmaceutical company with many employees all over the world. As of 2018, the highest proportion of AstraZeneca’s employees were based in the Asia-Pacific region. The global office and corporate headquarters of AstraZeneca is located in Cambridge in the United Kingdom. As of 2018, emerging markets and the U.S. market accounted for the highest revenues for AstraZeneca. The company is a leader in research and development globally as well.

AstraZeneca’s R&D

AstraZeneca has many research and development programs that are focused on addressing three main areas, oncology, cardiovascular, renal and metabolic diseases, and respiratory disease. AstraZeneca’s research and development expenditures have increased in recent years. In 2018, 28.2 percent of AstraZeneca’s total revenue was expended on research and development. And, as of early 2019, AstraZeneca was projected to be among the world’s top five pharmaceutical companies according to the number of drugs they had under development at that time.
Show more

Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical brands: Crestor and Nexium (AstraZeneca)
Pharmaceutical brands: Crestor and Nexium (AstraZeneca)

All Information
in one Presentation

Pharmaceutical brands: Crestor and Nexium (AstraZeneca)

Everything On "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)"
  • Overview
  • Drug prices and consumer behavior
  • Advertising expenditures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.